GS
IBB icon

GTS Securities’s iShares Biotechnology ETF IBB Stock Holding History

GTS Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,600
Closed -$3.44M – 2541
2024
Q3 		$3.44M Buy
23,600
+5,500
+30% +$796K 0.01% 1168
2024
Q2 		$2.48M Sell
18,100
-10,900
-38% -$1.46M 0.01% 1335
2024
Q1 		$3.98M Sell
29,000
-4,100
-12% -$560K 0.01% 1013
2023
Q4 		$4.5M Buy
33,100
+18,900
+133% +$2.31M 0.01% 1079
2023
Q3 		$1.74M Buy
+14,200
New +$1.81M ﹤0.01% 1621

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

GTS Securities's IBB Position: Q2 2026 in Review

GTS Securities reduced its iShares Biotechnology ETF (IBB) stake by 62% in Q2 2026, selling an estimated $391K and leaving 1,399 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #1041.

GTS Securities first reported a position in IBB in Q2 2023 and has held it in 12 quarters since. The position peaked at $9.26M in Q1 2025. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • GTS Securities held 1,399 shares of iShares Biotechnology ETF worth $266K as of Q2 2026.
  • GTS Securities sold 2,272 iShares Biotechnology ETF shares in Q2 2026, an estimated $391K.
  • iShares Biotechnology ETF made up 0.01% of GTS Securities's portfolio in Q2 2026, its #1041 holding.
  • GTS Securities first reported a position in iShares Biotechnology ETF in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's iShares Biotechnology ETF position peaked at $9.26M in Q1 2025.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.